This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of oesophagus
CD2_INSITU_OESOPHAGUS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditions
|
556605 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
49 |
4. Check minimum number of eventsNone |
49 |
5. Include endpointsNone |
49 |
6. Filter based on genotype QC (FinnGen only) |
45 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D00
- Name in latin
- Carcinoma in situ coli
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of oesophagus
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of oral cavity, oesophagus and stomach
- In situ neoplasms
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 45 | 14 | 31 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 69.63 | 70.95 | 69.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
103
4.41
5.95
3.7
2.7
—
—
—
0
0
18
61
4.16
4.94
6.4
4.9
33.58
30.00
%
0.51
12
38
14
42
4.32
4.46
3.1
3.0
0.19
0.21
g/l
0.49
14
37
34
191
3.82
4.25
6.4
3.2
—
—
estimate
—
0
0
40
269
4.26
3.86
6.6
5.7
6.97
6.81
mmol/l
0.19
40
260
28
148
3.21
3.69
2.0
1.8
18.66
22.93
nmol/l
0.95
23
122
13
49
3.29
2.91
9.8
10.0
—
—
—
0
0
41
313
3.42
2.55
4.2
5.1
13.78
13.58
mm/h
0.03
36
283
30
194
2.51
2.32
5.5
4.6
62.37
49.36
ng/l
0.17
25
158
29
187
2.44
2.22
3.0
2.8
75.13
78.29
nmol/l
0.21
23
167
17
86
2.53
2.20
3.0
2.7
22.98
24.03
%
0.09
12
81
7
156
0.35
2.07
2.3
3.2
0.00
0.35
e6/l
—
7
117
33
232
2.42
2.00
10.0
9.0
1.21
1.21
mmol/l
0.03
28
208
25
157
2.27
1.97
4.7
4.3
2.49
10.12
mg/mmol
1.72
15
110
31
215
2.30
1.90
10.9
5.4
35.06
34.70
g/l
0.14
31
204
25
163
2.14
1.73
2.6
2.0
1.09
1.34
mmol/l
0.74
19
131
30
213
2.13
1.64
3.3
2.4
87.78
89.92
pmol/l
0.10
21
122
5
21
2.54
1.12
3.4
2.0
423.80
557.05
ug/l
—
5
21
26
199
1.69
0.92
2.0
2.7
—
—
—
0
0
7
41
1.83
0.74
1.3
3.4
8.14
7.63
umol/l
—
7
35
18
133
1.57
0.69
2.5
3.0
30.56
30.78
u/l
0.02
18
125
9
63
1.53
0.57
2.0
1.8
—
—
—
0
0
12
84
1.58
0.56
1.9
2.1
0.56
1.46
mg/l
—
7
72
7
102
0.63
0.46
1.4
2.9
2.39
2.47
mmol/l
—
7
88
5
33
1.57
0.43
2.0
2.3
1.56
1.96
%
—
5
25
0
15
0.00
0.42
0.0
1.1
—
—
—
0
0
0
16
0.00
0.42
0.0
1.6
—
—
—
0
0
5
36
1.43
0.39
2.6
1.4
—
—
—
0
0
11
84
1.40
0.34
2.1
2.3
—
—
—
0
0
17
141
1.32
0.32
3.4
4.3
0.00
0.04
estimate
—
7
50
16
190
0.76
0.31
3.0
3.7
—
—
—
0
0
40
379
1.37
0.25
9.4
7.4
42.94
40.28
mmol/mol
0.81
32
358
7
91
0.73
0.25
3.1
3.8
396.43
175.00
ng/l
—
7
79
38
361
1.27
0.23
6.2
5.0
2.01
2.09
mu/l
0.11
30
324
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
16.09
—
0
11
0
12
0.00
0.21
0.0
2.8
—
273.42
—
0
12
0
12
0.00
0.21
0.0
1.8
—
116.51
—
0
7
22
239
0.85
0.15
3.5
4.6
0.00
0.00
estimate
—
7
52
22
238
0.86
0.14
3.7
4.5
0.00
28.00
estimate
—
7
58
22
235
0.88
0.10
3.7
4.5
0.00
0.00
estimate
—
6
54
17
175
0.96
0.00
3.9
4.8
0.00
0.06
estimate
—
5
47
18
182
0.98
0.00
4.9
5.3
19.96
21.51
%
—
9
97
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
8
81
0.99
0.00
7.3
6.9
102.00
103.67
mmol/l
—
8
81
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
-0.00
2.6
4.2
—
—
—
0
0
41
404
1.12
-0.00
7.4
6.4
2.25
2.55
mmol/l
1.22
36
371
0
5
0.00
-0.00
0.0
2.0
—
74.00
—
0
5
6
60
1.00
-0.00
2.3
2.0
—
—
—
0
0
40
396
1.07
-0.00
7.4
5.3
1.43
1.41
mmol/l
0.11
35
362
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
13
130
1.00
-0.00
2.9
4.3
0.00
0.00
estimate
—
5
43
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
40
396
1.07
-0.00
7.3
5.5
4.18
4.42
mmol/l
0.71
35
364
40
399
1.02
-0.00
7.6
5.6
6.06
6.08
mmol/l
0.05
33
365
0
8
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OESOPHAGUS – Carcinoma in situ of oesophagus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).